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Glycol ethers are known to produce embryotoxic and teratogenic effects in a variety ofanimal species. In
addition, testicular edema and tubular atrophy have been reported. The health effects of this class of
compounds are not known in humans, despite the fact that these solvents are widely used in industry.
In order to evaluate potential effects in humans, it is first necessary to estimate exposure in the
workplace (environmental monitoring). However, in the case of glycol ethers traditional air monitoring
may be ineffective because of the low volatility of these solvents and the possible significant exposure via
the skin.
Biological monitoring can be used to estimate glycol ether uptake by all routes of exposure. The
compounds can be measured in blood or their metabolites quantitated in urine. These procedures are
suggested for measuring 2-methoxyethanol, 2-ethoxyethanol and 2-butoxyethanol in blood. In addition,
tentative procedures have been developed to measure the oxidized acidic metabolites, methoxyacetic acid
and ethoxyacetic acid in urine as possible indices of exposure. All procedures have detection limits of less
than 11 parts per million. These procedures are ready to be validated in workers exposed to these solvents.
Introduction
Historically the alkoxy derivatives of ethylene glycol
were thought to be rather benign substances, but
experiments in animals have linked 2-methoxyethanol
(ME) and 2-ethoxyethanol (EE) or their metabolites
methoxyacetic acid (MAA) and ethoxyacetic acid (EAA)
to testicular edema and tubular atrophy (1,2). Adverse
reproductive effects have been noted for ME, EE and
2-butoxyethanol (BE). ME and EE were teratogenic
and embryotoxic in pregnant rats and rabbits while BE
produced microscopic testicular changes in mice (3). In
humans, reduced testicular size has been reported in
workers exposed to an industrial preparation containing
ME (4). No other adverse reproductive effects were
reported. Others have reported neurologic symptoms,
macrocytic anemia and abnormal leukocyte counts in
humans exposed to ME (5). Increased red cell fragility
was noted with BE exposure (6). Although there are
few reports relating adverse health effects with expo-
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sures to ME, EE and BE, these compounds are
receivinggreaterattentionbecause ofadversereproduc-
tive effects in both males and females ofseveral species
by a variety ofexposure routes (3). Further human field
and epidemiology studies are needed to address this
health risk if any in humans.
Ambient environmental sampling does not always
assess total worker exposure. The vapor pressures for
ME, EE and BE are low. These solvents also are readily
absorbed through the skin. Most workers are not
exposed to pure glycol ethers but to industrial formula-
tions containing mixtures of glycol ethers and other
solvents. In these instances, environmental monitoring
should be supplemented with biological monitoring to
evaluate not only exposure, but actual uptake of the
glycol ethers by the worker. The advantages of biologi-
cal monitoring are that it accounts for not only environ-
mental concentrations and actual respiratory uptake
but also absorption through the skin.
Blood from humans exposed to ME has been shown to
contain ME, so one matrix that might be suitable for
biological monitoring is blood (7). The oxidized acid
metabolites of these solvents have been reported in
humans and animals: butoxyacetic acid (BAA) in man
(8) and MAA, EAA, and BAA in animals (6,9,10). SoSMALLWOOD, DEBORD AND LOWRY
urinary MAA, EAA, and BAA may also be suitable for
biological monitoring.
Most biological monitoring methods must be sensitive
with low detection limits. Humans normally are not
exposed to the high concentrations of xenobiotics that
are often given to experimental animals; therefore, the
compounds being sought would be found in lower
concentrations than in animals. Theoretically, these low
levels are further reduced because the parent compound
may be metabolized, conjugated, stored or eliminated.
Often the compound is metabolized by more than one
route, therefore producing a myriad of possible meta-
bolic products and their conjugates at extremely low
concentration.
When an analyst is confronted with the task of
quantitating a substance in a blood or urine matrix, the
first approach is to isolate the compound from the
matrix. The characteristics that make ME, EE and BE
ideal for industrial applications make them a challenge
for an analytical chemist, that is, their simultaneous
lipophilic and hydrophilic properties and low vapor
pressures. The hydrophilic nature of glycol ethers
prevents their easy isolation from a urine or blood
matrix. Many standard gas chromatographic columns
will not simultaneously resolve ME, EE and BE, and
those that do may not resolve these three glycol ethers
from co-extracted substances. Resolution on porous
polymer columns are not sufficient, which precludes
direct injection ofdiluted blood. Low vapor pressure for
ME, EE and BE precludes headspace analysis. High
performance liquid chromatography (HPLC) is not
suitable because these compounds and theirmetabolites
do not absorb significantly in the ultraviolet. A gas-
liquid chromatographic analysis with flame ionization
detector seemed to be the best approach.
Before any analyses could be performed, these sol-
vents and their acid metabolites had to be isolated from
the blood and urine matrix. Methylene chloride is an
excellent solvent for extraction of ME, EE, BE, MAA
and EAA.
ME, EE, BE, MAA and EAA are very soluble in
methylene chloride. In addition, methylene chloride is
polar, not miscible with water and does not produce a
large response in a flame ionization detector.
The purpose of this study is to develop tentative
methods for analysis of ME, EE and BE in blood and
MAA and EAA in urine from humans. The ability to
analyze these substances should permit the evaluation
of worker uptake of these solvents and determine
whether these methods and analytes are suitable for
biological monitoring.
Materials and Methods
Chemicals
Ethoxyacetic acid (98%), and methoxyacetic acid
(99%) were obtained from Aldrich Chemical Co. (Mil-
waukee, WI). 2-Methoxyethanol (99%) was obtained
from MCB (Cincinnati, OH). 2-Ethoxyethanol (bp 133-
135°C) was obtained from Eastman Kodak (Rochester,
NY). 2-Butoxyethanol (99%) was obtained from Mal-
linckrodt (Paris, KY). Pentafluorobenzylbromide was
obtained from Pierce Chemical Company (Rockford,
IL). Tetrabutyl-ammonium hydrogen sulfate was ob-
tained from Regis Chemical Company (Morton Grove,
IL).
Standard Preparation
Standards containing ME, EE, and BE were pre-
pared in methylene chloride with concentrations rang-
ing from approximately 8 to 1000 ,ug/mL.
Standards containing MAA and EAA were prepared
in methylene chloride with concentrations ranging from
approximately 10 to 1000 pLg/mL. These acid metabolite
standards were then derivatized by using a modified
pentafluorobenzylation procedure (11) which is summa-
rized here. In a 16 x 150 mm culture tube containing 1
mL ofa standard solution is added 1 mL ofan aqueous
solution which is 0.1 M in tetrabutylammonium hydro-
gen sulfate and 0.2 M in sodium hydroxide. Then 100 FL
of pentafluorobenzyl bromide is added, and the tube
sealed and rotated for 2 hr (Roto-torque, Cole Palmer,
Chicago, IL). The methylene chloride phase contains
the derivatized acids.
Sample Preparation
Blood. A stock solution of the glycol ethers (ME,
EE, BE) was mixed with pooled human blood (EDTA
anticoagulant). This blood was then diluted with addi-
tional whole blood to obtain concentrations ranging
from approximately 8 to 1000 ,ug/g.
Urine. A stock solution of pooled urine containing
MAA and EAA was prepared. The stock urine was then
diluted with additional urine to obtain concentrations of
the acid metabolites ranging from approximately 10 to
1000 ,ug/mL.
Analytical Procedures
Blood. Blood (1 g), anhydrous sodium sulfate (1 g)
and methylene chloride (10 mL) were mixed on arotator
for 2.5 hr. The methylene chloride extract was filtered
and reduced in volume to 1 mL. A 3 ,uL portion was
injected into the gas chromatograph equipped with a
flame ionization detector (Perkin-Elmer Model 900,
Norwalk, CT). Theinstrument wasfitted with a25ft. x
1/8in. stainless steel column packed with 20% Carbowax
20 M on 80/100 mesh Supelcoport (Supelco, Belfonte,
PA). Conditions included an injection port temperature
of 220°C, column temperature of 200°C, manifold tem-
perature of 250°C, and nitrogen carrier gas of 15
mL/min. Peak area was calculated by using a computing
integrator (Spectra Physics Model 4000, SanJose, CA).
Urine. The spiked urine samples were acidified with
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HCIto pH 2. A 1 mL aliquot was extracted with 5 mL of
methylene chloride three times; the combined methy-
lene chloride extracts were evaporated to 1 mL, and
derivatized by using the pentafluorobenzylation proce-
dure described in the standard preparation section. A 5
,iL portion of the organic phase was injected into the
gas chromatograph (Thacor, Model 560, Austin, TX).
The instrument was fitted with a 6 ft. x 1/4 in. glass
column packed with 1.95% QF-1, 1.5% OV-17 on 80/100
Supelcoport. Conditions included an injection port tem-
perature of 200°C, a column temperature programmed
at 100°C for 2 min, then increasing 10°C/min to 220°C,
which was held for 2 min, a detector temperature of
250°C, and the nitrogen carrier flow at 30 mL/min. Peak
area was calculated using a computing integrator
(Spectra Physics, Model 4100, San Jose, CA).
Results
Blood
The results ofthe gas chromatographic separation of
ME, EE and BE in blood are shown in Figure 1. Figure
la shows a chromatogram of a blank unspiked blood
specimen; Figure lb shows the standards in methylene
chloride; Figure lc shows a chromatogram containing
100 ,ug/g of each glycol ether in blood. Approximate
retention times for ME, EE and BE are 5.0, 5.4 and 8.0
min, respectively.
Table 1 shows data on detection limits and recoveries
for the three glycol ethers in blood. Detection limits for
EE and BE are 5.0 and 4.0 ,ug/g blood, while ME had a
slightly larger detection limit of8.8 ,ug/g due to its close
proximity to the solvent front. Average recovery data
ranged from 78% for ME to 84% for EE over a wide
concentration range as shown in the table.
Urine
The results ofthe gas chromatographic separation of
the acid metabolites ofME and EE, MAA and EAA in
urine are shown in Figure 2. Figure 2a shows a
chromatogram of urine without added metabolites;
Figure 2b shows standards of the alkoxyacetic acids in
methylene chloride at 100 ,ug/mL each; Figure 2c shows
urine containing 100 ,ug/mL ofMAAand EAA. Approxi-
mate retention times for MAA and EAA are 4.9 and 5.4
min. Table 2 shows data on detection limits and recover-
ies for MAA and EAA in urine. Both compounds show
baseline resolution. Detection limits for MAA and EAA
are 11.4 and 5.0 ,ug/mL. Recoveries determined over a
concentration range ofapproximately 10 to 1000 ,ug/mL
ranged from 78% for MAA to 91% for EAA. Ranges of
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FIGURE 1. Gas chromatographic separation ofME, EE and BE in blood: (a) blood with no glycol ethers; (b) standard containing 100 ,g/mL of
each glycol ether; (c) blood containing 100 ,ug/g of each glycol ether:
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Table 1. Detection limits and recoveries of 2-methoxyethanol, 2-ethoxyethanol and 2-butoxyethanol in whole blood.
Concentration
Detection limit, range in Number of Average Recovery
Glycol ether ,ug/g blood, Rg/g extractions recovery, % RSD range, %
2-Methoxyethanol 8.8 88-946 10 78 0.106 63-94
2-Ethoxyethanol 5.0 8.6-895 15 84 0.091 71-99
2-Butoxyethanol 4.0 7.8-879 15 81 0.161 64-105
Table 2. Detection limits and recoveries for methoxyacetic acid and ethoxyacetic acid in urine.
Concentration
Detection limit, range in Number of Average Recovery
Compound ,g/mL urine, ,g/mL extractions recovery, % RSD range, %
Methoxyacetic acid 11.4 11.4-1140 15 78 0.17 54-96
Ethoxyacetic acid 5.0 10-1000 15 91 0.14 66-114
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FIGURE 2. Gas chromatographic separation of MAA and EAA in urine: (a) urine with no additions; (b) standards containing 100 ,ug/mL each
metabolite; (c) urine containing 100 ,ug/mL of each metabolite.
recoveries and relative standard deviations ofrecoveries
are shown in Table 2.
Discussion
The analysis of blood samples as indicators of expo-
sures of workers to ME, EE and BE has not been
employed. The pharmacokinetics, metabolism and elimi-
nation data in humans is not available. There is one
reference where glycol ethers were determined in blood
following dermal exposure. Nakaaki, Fukabori and
Osamu (7) exposed 12.5 cm2 of forearm to ME on two
human subjects. A rapid rise of ME in blood was
reported after 2 hr. The authors reported blood concen-
I
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trations of 106 to 493 [ug/mL. The methods used were
not detailed; however, a recovery of 66% was reported.
The author concluded that whole blood would be an
appropriate matrix for monitoring exposures to ME.
The method reported here has a wider analytical range,
lower detection limits and greater percent recoveries.
Therefore, a wider range of exposure at a multitude of
time intervals could be monitored.
Perhaps the best approach for biologically monitoring
ME, EE, and BE exposures is the quantitation of
MAA, EAA and BAA in urine. BE is metabolized to
BAA (6) in man. Animal studies have strongly sug-
gested that ME is metabolized to MAA in man (1,9).
There are more analytical techniques and information
available. relating to analyses of organic acids in urine.
Urine samples can be treated in a variety of ways to
assure stability of an analyte.
The acids MAA, EAA and BAA can be extracted and
derivatized with diazomethane, N,O-bis(trimethylsilyl)
trifluoroacetamide and bis(trimethylsilyl)acetamide
(11,12).
However, the pentafluorobenzylbromide was chosen
because it was a two-step extractive alkylation tech-
nique (11). This derivative had been used with some
success on butoxyacetic acid. The pentafluorobenzyl
derivatives are very electrophilic and would produce a
good response in electron capture detectors. This would
permit lower detection limits and the possibility of
quantitating MAA and EAA at the parts per billion
level. However, to extend the range to low parts per
billion, further isolation techniques need to be applied
to the analyte or its derivative. Sometimes double
extraction, each at different pH, is sufficient. Another
technique is to treat the sample with XAD resin
columns and elute with an appropriate solvent. The
most widely used cleanup technique incorporate Florisil
and silica gel columns utilizing a variety of nonelectro-
philic solvents. The incorporation of some ofthe above-
mentioned refinements would permit lower detection
limits and may allow monitoring of workers exposed to
low concentrations of glycol ethers.
The authors wish to thank D. Gayle DeBord for her extensive
bibliography on alkoxyethanols compiled while submitting a research
proposal for the Ph.D.
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